DE68926455D1 - Verfahren zur identifizierung von bakterien - Google Patents

Verfahren zur identifizierung von bakterien

Info

Publication number
DE68926455D1
DE68926455D1 DE68926455T DE68926455T DE68926455D1 DE 68926455 D1 DE68926455 D1 DE 68926455D1 DE 68926455 T DE68926455 T DE 68926455T DE 68926455 T DE68926455 T DE 68926455T DE 68926455 D1 DE68926455 D1 DE 68926455D1
Authority
DE
Germany
Prior art keywords
antisense oligonucleotide
operon
macromolecular synthesis
stranded dna
single stranded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926455T
Other languages
English (en)
Other versions
DE68926455T2 (de
Inventor
James Lupski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE68926455D1 publication Critical patent/DE68926455D1/de
Publication of DE68926455T2 publication Critical patent/DE68926455T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68926455T 1988-07-05 1989-06-30 Verfahren zur identifizierung von bakterien Expired - Fee Related DE68926455T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21513588A 1988-07-05 1988-07-05
PCT/US1989/002884 WO1990000624A1 (en) 1988-07-05 1989-06-30 Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria

Publications (2)

Publication Number Publication Date
DE68926455D1 true DE68926455D1 (de) 1996-06-13
DE68926455T2 DE68926455T2 (de) 1996-10-31

Family

ID=22801802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926455T Expired - Fee Related DE68926455T2 (de) 1988-07-05 1989-06-30 Verfahren zur identifizierung von bakterien

Country Status (7)

Country Link
EP (1) EP0424473B1 (de)
JP (1) JPH03505672A (de)
AT (1) ATE137806T1 (de)
AU (1) AU4180889A (de)
CA (1) CA1340796C (de)
DE (1) DE68926455T2 (de)
WO (1) WO1990000624A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) * 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
FR2651130B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Sequence d'oligonucleotides anti-sens, anti-arn message du tnf alpha, procede de preparation, application a titre de medicaments et compositions pharmaceutiques.
US5271941A (en) * 1990-11-02 1993-12-21 Cho Chung Yoon S Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
CA2126979A1 (en) * 1991-12-31 1993-07-22 Eliezer Rapaport Antiparasitic oligonucleotides active against drug resistant malaria
CA2161405A1 (en) * 1993-04-26 1994-11-10 James L. Doran Methods and compositions for detection of salmonella
AU7019794A (en) * 1993-05-26 1994-12-20 Genta Incorporated Oligomer conjugates and their use
US6440660B1 (en) 1995-11-17 2002-08-27 Hybridon, Inc. Oligonucleotide mediated reversal of drug resistance
US6096499A (en) * 1996-03-22 2000-08-01 Geron Corporation Mammalian DNA primase screen and activity modulating agents
AU4672097A (en) * 1996-10-01 1998-04-24 Advanced Research And Technology Institute, Inc. Methods and compositions for inhibiting bacterial growth
US6300318B1 (en) * 1997-09-16 2001-10-09 Peter E. Nielsen Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor
EP1088086A4 (de) 1998-06-24 2003-01-08 Musc Found For Res Dev Gewebe-spezifische sowie ziel-rna-spezifische ribozyme
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
EP1210365A2 (de) * 1999-08-17 2002-06-05 Beth Israel Deaconess Medical Center, Inc. Verfahren und zusammensetzungen zur wiederherstellung der empfindlichkeit zur antibiotika in glykopeptid-resistente enterococcus
US10400291B2 (en) 2014-06-27 2019-09-03 The Regents Of The University Of Michigan Method for bacterial species identification and strain typing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
JP2547714B2 (ja) * 1981-10-23 1996-10-23 モルキユラ− バイオシステムズ インコ−ポレテツド オリゴヌクレオチド治療剤及びその製法
US4740463A (en) * 1984-04-13 1988-04-26 Massachusetts Institute Of Technology Methods and artificial genes for antagonizing the function of an oncogene
US5024943A (en) * 1985-11-07 1991-06-18 Gist-Brocades Regulatory region cloning and analysis plasmid for bacillus
FR2596774B1 (fr) * 1986-04-04 1988-07-22 Pasteur Institut Sondes oligonucleotidiques et procedes pour la detection par hybridation des acides nucleiques de bacteries et autres etres vivants
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US4801540A (en) * 1986-10-17 1989-01-31 Calgene, Inc. PG gene and its use in plants

Also Published As

Publication number Publication date
JPH03505672A (ja) 1991-12-12
EP0424473A4 (en) 1992-12-09
EP0424473A1 (de) 1991-05-02
CA1340796C (en) 1999-10-19
EP0424473B1 (de) 1996-05-08
WO1990000624A1 (en) 1990-01-25
DE68926455T2 (de) 1996-10-31
AU4180889A (en) 1990-02-05
ATE137806T1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
CA2048450A1 (en) Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
ATE137806T1 (de) Verfahren zur identifizierung von bakterien
FR2685346B1 (fr) Procede de preparation d'arn double-brin, et ses applications.
BR9206049A (pt) Composto, processos para preparar o composto, para o reconhecimento específico por sequência de um polinucleotídio de filamento duplo, para modular a expressão de um gene em um organismo, para tratar as condições associadas com produção de proteínas indesejada em um organismo, para induzir a degradação de DNA ou RNA em células de um organismo e para exterminar células ou vírus e composição farmacêutica
DE58908694D1 (de) Oligonucleotidbank und verfahren zur dna-sequenzierung.
ATE515510T1 (de) Durch dna-abschnitte unterbrochene modifizierte oligonukleotide
DE69729179D1 (de) Kohlenhydratmodifizierte luckenhafte oligonukleotide
EP0828849A4 (de) Oligonukleotidliganden mit hoher affinität für wachstumsfaktoren
EP1961826A3 (de) Verfahren zur direkten Sequenzierung von Nukleinsäuren
FI951612A (fi) Menetelmiä synteettisten oligonukleotidien sekvensoimiseksi, jotka sisältävät nukleotidien välisiä ei-fosfodiesterisidoksia
NO930515D0 (no) Oligonukleotider for modulering av effektene av cytomegalovirusinfeksjoner
ATE419262T1 (de) 2'-o-acetamido-modifizierte monomere und oligomere
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69627314D1 (de) Kettenabbruchgruppen, ihre verwendung zur sequenzierung und synthese von nukleinsäuren und verfahren zu ihrer herstellung
DE69331665D1 (de) Methode zur behandlung von nukleinsäureproben
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
DE3583564D1 (de) Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
ATE258596T1 (de) Antigens-nukleinsäure enthaltende pharmazeutische zusammensetzung zur verbeugung und/oder behandlung von neuronalen verletzungen, entartungen und zellentot, und zur behandlung von neoplasmen
DE69638166D1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
UA43308C2 (uk) Спосіб надання рослині резистентності до склеротиніозу
DE69739585D1 (de) Verfahren und dns-konstrukte zur hemmung der genexpression in bakterien.
DE59608651D1 (de) Verfahren zur sequenzierung durch oligomerhybridisierung
EP0739987A3 (de) Oligonukleotide und Verfahren für den Nachweis von Salmonella
ATE108834T1 (de) Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke.
RU2002109243A (ru) Способ идентификации фармацевтических агентов из растительных экстрактов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee